This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing the potential of VUITY in treating presbyopia
Ticker(s): ABBVWho's the expert?
Institution: Family Eye Care
- I see roughly 200 patients in a month who have presbyopia. I am familiar with VUITY, and have prescribed it for a handful of patients
- I've practiced optometry for the past 8 years. I've done a little bit of everything - pediatric optometry, vision therapy, specialty contact lens fits, and ocular disease. Lately, I have chosen to specialize more in ocular disease and dry eye. I try to stay up-to-date on the latest and greatest therapies available. I would consider myself to be an early adopter of new innovations in optometry, compared to my peers.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
